<DOC>
	<DOCNO>NCT01074632</DOCNO>
	<brief_summary>The objective study evaluate effect calorie fat content pharmacokinetics Lurasidone HCl subject schizophrenia , schizoaffective disorder , schizophreniform disorder .</brief_summary>
	<brief_title>Effect Calories Fat Content Pharmacokinetics Lurasidone HCl</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Male female 18 65 year age BMI &gt; = 19.5 &lt; = 37 kg/m2 No clinically relevant abnormal laboratory value History presence renal hepatic insufficiency Participated clinical trial past 30 day Use con med prolong QT/QTc take within 14 day prior study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>